Moreover, our group has demonstrated that the mGluR5 PAM, CDPPB, can promote neuroprotection in vitro and that the chronic treatment of a mouse model of HD with CDPPB can prevent neuronal cell loss, decrease huntingtin aggregate formation and rescue memory deficit [10, 11]. Here, GRM5 is linked to Huntington disease.